Thomas Nolte

Summary

Affiliation: Boehringer Ingelheim

Publications

  1. doi request reprint RITA--Registry of Industrial Toxicology Animal data: the application of historical control data for Leydig cell tumors in rats
    Thomas Nolte
    Boehringer Ingelheim Pharma GmbH and Co KG, Nonclinical Drug Safety Germany, Birkendorfer Strasse 65, D 88397 Biberach Riss, Germany
    Exp Toxicol Pathol 63:645-56. 2011
  2. ncbi request reprint Standardized assessment of cell proliferation: the approach of the RITA-CEPA working group
    Thomas Nolte
    Boehringer Ingelheim Pharma GmbH and Co KG, Dpt Non Clinical Drug Safety, 88397 Biberach Riss, Germany
    Exp Toxicol Pathol 57:91-103. 2005
  3. doi request reprint Improved lipid profile through liver-specific knockdown of liver X receptor alpha in KKAy diabetic mice
    Joerg F Rippmann
    Department of Pulmonary Diseases Research, Boehringer Ingelheim Pharma GmbH and Co KG, 88397 Biberach, Germany
    J Lipid Res 50:22-31. 2009

Collaborators

  • Joerg F Rippmann
  • Andre van Marle
  • Corinna Schoelch
  • Juergen Prestle
  • Helmuth van Es
  • Heidi Pavliska

Detail Information

Publications3

  1. doi request reprint RITA--Registry of Industrial Toxicology Animal data: the application of historical control data for Leydig cell tumors in rats
    Thomas Nolte
    Boehringer Ingelheim Pharma GmbH and Co KG, Nonclinical Drug Safety Germany, Birkendorfer Strasse 65, D 88397 Biberach Riss, Germany
    Exp Toxicol Pathol 63:645-56. 2011
    ..Furthermore, it demonstrates that the RITA database is highly beneficial for the definition of reliable historical control data for carcinogenicity studies on a scientifically solid basis...
  2. ncbi request reprint Standardized assessment of cell proliferation: the approach of the RITA-CEPA working group
    Thomas Nolte
    Boehringer Ingelheim Pharma GmbH and Co KG, Dpt Non Clinical Drug Safety, 88397 Biberach Riss, Germany
    Exp Toxicol Pathol 57:91-103. 2005
    ..Membership of the CEPA group is open for all industrial organizations who develop chemical, agrochemical, or pharmaceutical products...
  3. doi request reprint Improved lipid profile through liver-specific knockdown of liver X receptor alpha in KKAy diabetic mice
    Joerg F Rippmann
    Department of Pulmonary Diseases Research, Boehringer Ingelheim Pharma GmbH and Co KG, 88397 Biberach, Germany
    J Lipid Res 50:22-31. 2009
    ..Taken together, liver-specific knockdown of LXRalpha in vivo by shRNA reduced expression of lipogenic master genes, like SREBP1c, and improved the lipid profile of hypertriglyceridemic KKAy mice...